BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«KIR3DL1

Below is an extended KIR3DL1 research listing. Click here to return to the KIR3DL1 main in depth entry.

Recent Publications on KIR3DL1:

A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection.
OBJECTIVES: Coexpression of certain combinations of natural killer cell...
Direct Link
22nd August, 2008
Research Institute of the McGill University Health Centre, Canada.
Investigation of killer cell immunoglobulin-like receptor gene diversity in KIR3DL1 and KIR3DS1 in a transplant population.
Several overlapping amplicons were used to obtain the sequence of genomic...
Direct Link
8th August, 2008
Department of Pediatrics, CW Bill Young Marrow Donor Recruitment and
Amino-acid sequence motifs for PKC-mediated membrane trafficking of the inhibitory killer Ig-like receptor.
Activation-induced upregulation of inhibitory killer Ig-like receptor...
Direct Link
5th August, 2008
Department of Microbiology and Brain Korea 21 Project of Medical Sciences,
Killer Ig-like receptor expression in uterine NK cells is biased toward recognition of HLA-C and alters with gestational age. 29th July, 2008
Department of Pathology, University of Cambridge, Cambridge, United
The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplantations.
Natural killer (NK)-cell alloreactivity can be exploited in haploidentical...
Direct Link
24th July, 2008
School of Pathology and Laboratory Medicine, University of Western
Activating KIR genes are associated with ankylosing spondylitis in Asian populations.
Killer cell immunoglobulin-like receptors (KIRs) and human leukocyte...
Direct Link
22nd July, 2008
Department of Immunology, Hospital Universitario Central de Asturias,
Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals.
Birdshot chorioretinopathy (BCR), a chronic ocular inflammatory disease...
Direct Link
17th July, 2008
Ocular Inflammatory Disease Center, Jules Stein Eye Institute, David
[Promoter methylation regulates KIR3DL1 gene expression in NK-92MI cell line.] 12th July, 2008
Department of Hematology, General Hospital of PLA, Beijing 100853, China.
[Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation] 12th July, 2008
Department of Hematology, General Hospital of Chinese People's Liberation
Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation? 20th June, 2008
Cancer and Inflammation Program, Laboratory of Experimental Immunology,
[DNA methylation regulates kir3dl1 gene expression in k562 cell line] 14th June, 2008
Department of Hematology, General Hospital of PLA, Beijing 100853, China.
Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1.
Inhibitory killer cell immunoglobulin receptors (KIR) bind to major...
Direct Link
27th May, 2008
Department of Hematology, University Hospital Basel, Basel, Switzerland.
E2F1 contributes to the transcriptional activation of the KIR3DL1 gene.
The KIR3DL1 gene is a member of killer immunoglobulin-like receptors...
Direct Link
23rd May, 2008
Department of Hematology, General Hospital of PLA, 28 Fuxing Road, Beijing
HLA alleles determine differences in human natural killer cell responsiveness and potency.
Epidemiological studies have associated certain human disease outcomes...
Direct Link
30th April, 2008
Howard Hughes Medical Institute, Department of Medicine, Washington
[Construction of kir3dl1 promoter expression vector and its activity in K562 cell line] 23rd April, 2008
Department of Hematology, General Hospital of PLA, Beijing 100853, China.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional